• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺衍生的ETS因子通过抑制乳腺癌的迁移和侵袭,成为转移潜能的一个介质。

Prostate-derived ETS factor is a mediator of metastatic potential through the inhibition of migration and invasion in breast cancer.

作者信息

Turner David P, Moussa Omar, Sauane Moira, Fisher Paul B, Watson Dennis K

机构信息

Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.

出版信息

Cancer Res. 2007 Feb 15;67(4):1618-25. doi: 10.1158/0008-5472.CAN-06-2913.

DOI:10.1158/0008-5472.CAN-06-2913
PMID:17308102
Abstract

Cell migration and invasion are critical events during the progression to metastasis. Without motile function, cancer cells are unable to leave the primary tumor site, invade through the basement membrane, and form secondary tumors. Expression of the epithelial-specific ETS factor prostate-derived ETS factor (PDEF) is reduced in human invasive breast tissue and lost in invasive breast cancer cell lines. Gain-of-function studies that examine different aspects of cell migration show that constitutive or inducible PDEF reexpression inhibits migration and invasion in multiple breast cancer cell lines, and loss-of-function studies show a stimulation of migration in noninvasive breast cancer cells. Furthermore, the introduction of PDEF into invasive breast cancer cells led to a remodeling of the actin cytoskeleton and altered focal adhesion localization and adherence levels. Cells expressing PDEF no longer form the defined morphologic polarity required for efficient, directional migration. Collectively, these data indicate that PDEF down-regulation in invasive breast cancer may promote actin-mediated cell migration through the extracellular matrix.

摘要

细胞迁移和侵袭是肿瘤转移过程中的关键事件。如果没有运动功能,癌细胞就无法离开原发肿瘤部位,穿透基底膜并形成继发性肿瘤。上皮特异性ETS因子前列腺源性ETS因子(PDEF)在人侵袭性乳腺组织中的表达降低,在侵袭性乳腺癌细胞系中则缺失。研究细胞迁移不同方面的功能获得性研究表明,组成型或诱导型PDEF重新表达可抑制多种乳腺癌细胞系的迁移和侵袭,而功能缺失性研究表明,非侵袭性乳腺癌细胞的迁移会受到刺激。此外,将PDEF导入侵袭性乳腺癌细胞会导致肌动蛋白细胞骨架重塑,并改变粘着斑的定位和粘附水平。表达PDEF的细胞不再形成高效定向迁移所需的明确形态极性。总体而言,这些数据表明,侵袭性乳腺癌中PDEF的下调可能通过细胞外基质促进肌动蛋白介导的细胞迁移。

相似文献

1
Prostate-derived ETS factor is a mediator of metastatic potential through the inhibition of migration and invasion in breast cancer.前列腺衍生的ETS因子通过抑制乳腺癌的迁移和侵袭,成为转移潜能的一个介质。
Cancer Res. 2007 Feb 15;67(4):1618-25. doi: 10.1158/0008-5472.CAN-06-2913.
2
Pdef expression in human breast cancer is correlated with invasive potential and altered gene expression.Pdef在人类乳腺癌中的表达与侵袭潜能及基因表达改变相关。
Cancer Res. 2003 Aug 1;63(15):4626-31.
3
Proteomic analysis of a PDEF Ets transcription factor-interacting protein complex.一种PDEF Ets转录因子相互作用蛋白复合体的蛋白质组学分析。
J Proteome Res. 2009 Mar;8(3):1327-37. doi: 10.1021/pr800683b.
4
Prostate derived ETS factor (PDEF): a putative tumor metastasis suppressor.前列腺衍生 ETS 因子 (PDEF):一种潜在的肿瘤转移抑制因子。
Cancer Lett. 2011 Nov 1;310(1):109-17. doi: 10.1016/j.canlet.2011.06.011. Epub 2011 Jun 29.
5
Positive regulation of migration and invasion by vasodilator-stimulated phosphoprotein via Rac1 pathway in human breast cancer cells.血管舒张刺激磷蛋白通过Rac1途径对人乳腺癌细胞迁移和侵袭的正向调控
Oncol Rep. 2008 Oct;20(4):929-39.
6
Sam-pointed domain containing Ets transcription factor in luminal breast cancer pathogenesis.在管腔型乳腺癌发病机制中含Ets转录因子的Sam结构域。
Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1899-903. doi: 10.1158/1055-9965.EPI-09-0055.
7
Hypoxia/reoxygenation: a dynamic regulator of lysyl oxidase-facilitated breast cancer migration.缺氧/复氧:赖氨酰氧化酶促进乳腺癌迁移的动态调节因子
J Cell Biochem. 2008 Apr 1;103(5):1369-78. doi: 10.1002/jcb.21517.
8
Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.芹菜素通过阻断PI3K/Akt信号通路和β4整合素功能抑制HGF促进的MDA-MB-231乳腺癌细胞侵袭性生长和转移。
Toxicol Appl Pharmacol. 2008 Jan 15;226(2):178-91. doi: 10.1016/j.taap.2007.09.013. Epub 2007 Sep 21.
9
HOXB13 regulates the prostate-derived Ets factor: implications for prostate cancer cell invasion.HOXB13调控前列腺源性Ets因子:对前列腺癌细胞侵袭的影响。
Int J Oncol. 2014 Aug;45(2):869-76. doi: 10.3892/ijo.2014.2485. Epub 2014 Jun 3.
10
Expression of estrogen receptor beta increases integrin alpha1 and integrin beta1 levels and enhances adhesion of breast cancer cells.雌激素受体β的表达增加整合素α1和整合素β1的水平,并增强乳腺癌细胞的黏附。
J Cell Physiol. 2010 Jan;222(1):156-67. doi: 10.1002/jcp.21932.

引用本文的文献

1
Discovery of therapeutic targets in cancer using chromatin accessibility and transcriptomic data.利用染色质可及性和转录组数据发现癌症治疗靶点。
Cell Syst. 2024 Sep 18;15(9):824-837.e6. doi: 10.1016/j.cels.2024.08.004. Epub 2024 Sep 4.
2
The analysis of transcriptomic signature of TNBC-searching for the potential RNA-based predictive biomarkers to determine the chemotherapy sensitivity.三阴性乳腺癌转录组特征分析——寻找潜在的基于RNA的预测生物标志物以确定化疗敏感性。
J Appl Genet. 2025 Feb;66(1):171-182. doi: 10.1007/s13353-024-00876-x. Epub 2024 May 9.
3
A mucus production programme promotes classical pancreatic ductal adenocarcinoma.
黏液产生程序促进经典型胰腺导管腺癌。
Gut. 2024 May 10;73(6):941-954. doi: 10.1136/gutjnl-2023-329839.
4
Discovery of Potent Indolyl-Hydrazones as Kinase Inhibitors for Breast Cancer: Synthesis, X-ray Single-Crystal Analysis, and In Vitro and In Vivo Anti-Cancer Activity Evaluation.强效吲哚腙类化合物作为乳腺癌激酶抑制剂的发现:合成、X射线单晶分析以及体外和体内抗癌活性评估
Pharmaceuticals (Basel). 2023 Dec 13;16(12):1724. doi: 10.3390/ph16121724.
5
Design and Synthesis of Novel Pyridine-Based Compounds as Potential PIM-1 Kinase Inhibitors, Apoptosis, and Autophagy Inducers Targeting MCF-7 Cell Lines: In Vitro and In Vivo Studies.新型吡啶基化合物作为潜在的PIM-1激酶抑制剂、凋亡和自噬诱导剂靶向MCF-7细胞系的设计与合成:体外和体内研究
ACS Omega. 2023 Nov 27;8(49):46922-46933. doi: 10.1021/acsomega.3c06700. eCollection 2023 Dec 12.
6
SPDEF enhances cancer stem cell-like properties and tumorigenesis through directly promoting GALNT7 transcription in luminal breast cancer.SPDEF 通过直接促进腔乳腺癌中 GALNT7 转录来增强癌症干细胞样特性和致瘤性。
Cell Death Dis. 2023 Aug 26;14(8):569. doi: 10.1038/s41419-023-06098-z.
7
In Silico Identification of Genes Associated with Breast Cancer Progression and Prognosis and Novel Therapeutic Targets.乳腺癌进展、预后相关基因及新型治疗靶点的计算机模拟鉴定
Biomedicines. 2022 Nov 21;10(11):2995. doi: 10.3390/biomedicines10112995.
8
The subtype-specific molecular function of SPDEF in breast cancer and insights into prognostic significance.SPDEF 在乳腺癌中的亚型特异性分子功能及对预后意义的深入了解。
J Cell Mol Med. 2021 Aug;25(15):7307-7320. doi: 10.1111/jcmm.16760. Epub 2021 Jun 30.
9
Characterization of Neoantigen Load Subgroups in Gynecologic and Breast Cancers.妇科和乳腺癌中新抗原负荷亚组的特征分析
Front Bioeng Biotechnol. 2020 Jul 13;8:702. doi: 10.3389/fbioe.2020.00702. eCollection 2020.
10
Double Agent: Gene with Both Oncogenic and Tumor-Suppressor Functions in Breast Cancer.双重角色:在乳腺癌中兼具致癌和抑癌功能的基因
Cancer Manag Res. 2020 May 25;12:3891-3902. doi: 10.2147/CMAR.S243748. eCollection 2020.